Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model

Brain metastases are common in patients with non-small-cell lung cancer (NSCLC). The efficacy of bevacizumab, an anti-vascular endothelial growth factor (VEGF) humanized antibody, has been demonstrated in patients with nonsquamous NSCLC. We established a transplantable NSCLC cell line (Nluc-H1915) t...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Exp Metastasis
Auteurs principaux: Masuda, Chinami, Sugimoto, Masamichi, Wakita, Daiko, Monnai, Makoto, Ishimaru, Chisako, Nakamura, Ryo, Kinoshita, Mari, Yorozu, Keigo, Kurasawa, Mitsue, Kondoh, Osamu, Yamamoto, Kaname
Format: Artigo
Langue:Inglês
Publié: Springer Netherlands 2019
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7007905/
https://ncbi.nlm.nih.gov/pubmed/31768815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10585-019-10008-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires